Vanguard Group’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Hold |
1,035,947
| – | – | ﹤0.01% | 3719 |
|
|
2025
Q1 | $1.41M | Hold |
1,035,947
| – | – | ﹤0.01% | 3599 |
|
|
2024
Q4 | $1.43M | Sell |
1,035,947
-5,580
| -0.5% | -$7.7K | ﹤0.01% | 3657 |
|
|
2024
Q3 | $1.11M | Hold |
1,041,527
| – | – | ﹤0.01% | 3735 |
|
|
2024
Q2 | $2.24M | Sell |
1,041,527
-6,242
| -0.6% | -$13.4K | ﹤0.01% | 3522 |
|
|
2024
Q1 | $3.41M | Sell |
1,047,769
-4,822
| -0.5% | -$15.7K | ﹤0.01% | 3432 |
|
|
2023
Q4 | $21.6M | Buy |
1,052,591
+112,700
| +12% | +$2.31M | ﹤0.01% | 2561 |
|
|
2023
Q3 | $15.1M | Buy |
939,891
+387,092
| +70% | +$6.22M | ﹤0.01% | 2670 |
|
|
2023
Q2 | $4.7M | Sell |
552,799
-49,126
| -8% | -$418K | ﹤0.01% | 3334 |
|
|
2023
Q1 | $5.94M | Buy |
601,925
+12,525
| +2% | +$124K | ﹤0.01% | 3220 |
|
|
2022
Q4 | $5.62M | Buy |
589,400
+404,946
| +220% | +$3.86M | ﹤0.01% | 3249 |
|
|
2022
Q3 | $3.21M | Buy |
184,454
+2,063
| +1% | +$35.9K | ﹤0.01% | 3547 |
|
|
2022
Q2 | $1.41M | Buy |
182,391
+107,658
| +144% | +$834K | ﹤0.01% | 3966 |
|
|
2022
Q1 | $1.13M | Buy |
+74,733
| New | +$1.13M | ﹤0.01% | 4168 |
|